T. Tang, Q. Xia, J. Guo et al.
Journal of Molecular Liquids 338 (2021) 116451
the application of our material in the bio-assay against colorectal
3.73 (br, 4H), 2.62 (br, 4H). 13C NMR (CDCl
131.77, 129.71, 128.27, 128.19, 123.01, 113.56, 88.26, 85.34,
3
, 62.9 MHz): 159.22,
(
Ramos.2G6.4C10, HCT-8 [HRT-18], and HCT 116) cancer cell lines.
6
7.13, 61.44, 55.27, 49.79.
2
. Experimental
2
3 4
.5. Determination of the antioxidant activities of Fe O @T. spicata/Ag
2.1. Material
nanocomposite
Antimycotic antibiotic solution, dimethyl sulfoxide (DMSO),
To study the radical scavenging antioxidant property of our Fe
@T. spicata/Ag nanocomposite, DPPH (2,2-diphenyl-1-
picrylhydrazyl) is being used [1-3].
3
-
hydrolyzate, Ehrlich solution, decamplmaneh fetal bovine serum,
borax-sulfuric acid mixture, Dulbazolic mixture Modified Eagle
Medium (DMED), 4- (Dimethylamino) benzaldehyde, 2,2-
diphenyl-1- pikrilhydrazil (DPPH) and phosphate buffer solution
O
4
A 39.4% DPPH solution (w/V) was prepared in 1:1 aqueous
3 4
MeOH. At the same time, different samples of Fe O @T. spicata/
(
PBS) were supplied from the US Sigma-Aldrich company.
Ag nanocomposite of variable concentrations (0–1000 µg/mL) were
3 4
prepared. The DPPH solution was then added to Fe O @T. spicata/
Ag nanocomposite samples and incubated at 37 °C.
2.2. Preparation of Thymbra spicata leaf extract
After 30 min of incubation, the absorbances of the mixtures
were measured at 570 nm. MeOH (50%) and butylated hydroxy-
toluene (BHT) were considered as negative and positive controls
respectively in the study.
The antioxidant property of Fe O @T. spicata/Ag nanocomposite
3 4
was determined in terms of % inhibition and expressed as
One hundred grams of Thymbra spicata dried leaves were
ground and refluxed at 70 °C with 500 mL of sterile distilled water
for 2 h. Afterward, the mixture was cooled down to room temper-
ature. The aqueous extract of Thymbra spicata leaves was cen-
trifuged at 6500 rpm. Moreover, the supernatant was separated
o
by filtration and was kept in a refrigerator at 4 C for later
investigations.
Sample A:
Control A:
Inhibition ð%Þ ¼
ꢀ 100
2.3. Preparation of the biologically active magnetic Fe
3 4
O @T. spicata/
Ag nanocomposite
2
.6. Determination of anti-human colorectal cancer properties of
O
3 4
In the first step, magnetite nanoparticle (0.5 g) was dispersed in
00 mL water and sonicated for 20 min at 60 °C. Next, the Thymbra
Fe @T. spicata/Ag nanocomposite
1
spicata extract was added to the mixture. Afterwards, the solution
was sonicated again at this temperature for 60 min, and subse-
quently, a solution of AgNO in water was added dropwise using
3
a dropping funnel in the reaction media (0.03 g, 20 mL, the drip
rate was 1 mL/min) under sonication. After complete addition,
the reaction continued for another 60 min under ultrasonic condi-
tions. Then, the mixture was cooled to room temperature and the
In this assay, following human colorectal cancer cell lines and
the normal cell line (HUVEC) were used to study the cytotoxicity
and anticancer potentials of human colorectal over the Fe @T.
spicata/Ag nanocomposite using the common cytotoxicity experi-
ment i.e., MTT assay in vitro condition:
3 4
O
(
A) Normal cell line
3 4
magnetic nanoparticles Fe O @T. spicata/Ag as a dark solid was iso-
–
HUVEC.
lated from the solution by magnetic separation and washed several
times by DI water and ethanol. The final nanocomposite was dried
in a vacuum at 40 °C. The concentration of silver was 0.041 mmol/
g, which was determined by ICP-OES.
(
B) Colorectal cancer cell lines
–
–
–
Ramos.2G6.4C10
HCT-8 [HRT-18]
HCT 116
2
.4. General procedure for the synthesis of Propargylamines catalyzed
For culturing the above cells, different materials including peni-
cillin, streptomycin, and Dulbecco’s modified Eagle’s medium
by Fe @T. spicata/Ag nanocomposite
3 4
O
(
DMEM) were used [2,3]. In this test, the distribution of cells was
A mixture of aldehyde (1 mmol), amine (1 mmol), phenyl acet-
ylene (1.2 mmol) and Fe @T. spicata/Ag nanocomposite (20 mg,
.1 mol%) was heated in water (3 mL) at 80 °C for requisite times.
After completion (as monitored by TLC), the catalyst was retrieved
by a magnet for recycling. The reaction mixture was extracted with
ethyl acetate, concentrated and purified through column chro-
matography (7:3, Hexane/EtOAc).
10,000 cells/well in 96-well plates.
O
3 4
All samples were transferred to a humidified incubator contain-
0
ing 5% CO
with the different Fe O
2
at 37 °C. After 24 h incubation, all cells were treated
@T. spicata/Ag nanocomposite samples
3 4
(0–1000 µg/mL) and incubated again for 24 h. Subsequently, they
were sterilized by UV-radiation for 2 h. Then 5 mg/mL of MTT
was added to all wells and incubated again for 4 h at 37 °C.
The percentage of cell viability of samples were determined fol-
lowing the given formula after the measurement of absorbance at
570 nm.
1
13
2
.4.1. H NMR and C NMR for selected products in the Table 2:
1
(
Table 2, entry 1): H NMR (CDCl
3
, 250 MHz): d 7.65–7.62 (m,
2
2
1
H), 7.51 (m, 2H), 7.37–7.26 (m, 6H), 4.80 (s, 1H), 3.74 (br, 4H),
1
3
Sample A:
Control A:
.64 (br, 4H), CNMR (CDCl
28.21, 127.76, 122.97, 88.49, 85.03, 67.13, 62.03, 49.86.
Table 2, entry 6): 1HNMR (CDCl
, 250 MHZ): d 7.52–7.49 (m,
H), 7.34–7.16 (m, 5H), 4.75 (s, 1H), 3.73–3.71 (br, 4H), 2.63 (br,
3
, 62.9 MHz): 137.77, 131.79, 128.57,
Cell viability ð%Þ ¼
ꢀ 100
(
3
4
4
1
6
1
3
H), 2.36 (s, 3H).
31.78, 128.90, 128.50, 128.27, 128.18, 123.03, 88.23, 85.32,
7.15, 61.78, 49.86, 21.10.
3
NMR (CDCl , 62.9 MHz): 137.47, 134.78,
2.7. Qualitative measurement
The obtained results were loaded into the ‘‘SPSS-22” program
and evaluated by ‘‘one-way ANOVA”, accompanied by a ‘‘Duncan
post-hoc” check (p ꢁ 0.01).
(
Table 2, entry 7): 1H NMR (CDCl
3
, 250 MHZ): d 7.55–7.52 (m,
4
H), 7.33–7.26 (m, 3H), 6.92–68 (d, 2H), 4.74 (s, 2H), 3.82 (s, 3H),
3